Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II TrialPhilippe Armand, Leo I. Gordon, David Avigan et al.|Journal of Clinical Oncology|2013Cited by 439
High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapyGeorge Mellgard, Rajshekhar Chakraborty, Divaya Bhutani et al.|Bone Marrow Transplantation|2024Cited by 2